Protection of erythropoietin on experimental spinal cord injury by reducing the expression of thrombospondin-1 and transforming growth factor-β

被引:18
|
作者
Fang Xiang-qian [2 ]
Fang Mei
Fan Shun-wu [2 ]
Gu Chuan-long [1 ]
机构
[1] Zhejiang Univ, Dept Cell Biol & Anat, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China
[2] Zhejiang Univ, Dept Orthopaed, Sch Med, Sir Run Run Shaw Hosp, Hangzhou 310016, Zhejiang, Peoples R China
关键词
thrombospondin-1; transforming growth factor-beta; spinal cord injury; erythropoietin; TGF-BETA; COLLAGEN; MODEL; RAT;
D O I
10.3760/cma.j.issn.0366-6999.2009.14.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Erythropoietin (EPO) functions as a tissue-protective cytokine in addition to its crucial hormonal role in red cell production and neuron protection. This study aimed to determine the neuron protective effect of erythropoietin on experimental rats enduring spinal cord injury (SCI) by assessing thrombospondin-1 (TSP-1) level and transforming growth factor-beta (TGF-beta) in the development of a rat model of SCI. Methods Sixty Sprague-Dawley rats were randomly assigned to three groups: sham operation control group, SCI group and EPO treatment group. By using a weight-drop contusion SCI model, the rats in the SCI group and EPO treatment group were sacrificed at 24 hours and 7 days subsequently. The Basso, Beattie, and Bresnahan (BBB) scores were examined for locomotor function. Pathological changes were observed after HE staining. The expressions of thrombospondin-2 (TSP-1) and TGF-beta were determined by immunohistochemical staining and Western blotting. Results Slighter locomotor dysfunction was discovered and it was recovered abruptly as higher BIBB scores were found in the EPO treatment group than in the SCI group (P<0.01). Pathologically, progressive disruption of the dorsal white matter and regeneration of a few neurons were also observed in SCI rats. TSP-1 and TGF-beta expression increased at 24 hours and 7 days after SCI in the injured segment, and it was higher in the SCI group than in the EPO treatment group. Spinal cord samples from the animals demonstrated a TSP-1 optical density of 112.2 +/- 6.8 and TSP-1 positive cells of 5.7 +/- 1.3 respectively. After injury, the TSP-1 optical density and cell number increased to 287.2 +/- 14.3/mm(2) and 23.2 +/- 2.6/mm(2) at 24 hours and to 232.1 +/- 13.2/mm(2) and 15.2 +/- 2.3/mm(2) at 7 days respectively. When EPO treated rats compared with the SCI rats, the TSP-1 optical density and cell number decreased to 213.1 +/- 11.6/mm(2) and 11.9 +/- 1.61mm(2) at 24 hours and to 189.9 +/- 10.5/mm(2) and 9.3 +/- 1.5/mm(2) at 7 days, respectively (P<0.01). In the SCI rats, the TGF-beta optical density and positive neuron number were 291.4 +/- 15.2/mm(2) and 28.8 +/- 4.9/mm(2) at 24 hours and 259.1 +/- 12.3/mm(2) and 23.9 +/- 4.1/mm(2) at 7 days respectively. They decreased in the EPO treated rats to 222.8 +/- 11.9/mm(2) and 13.7 +/- 2.1/mm(2) at 24 hours and to 196.5 +/- 9.7/mm(2) and 8.7 +/- 2.2/mm(2) at 7 days (P<0.01). Conclusions Increased expression of TSP-1 and TGF-beta can be found in the injured segment of the spinal cord at 24 hours and 7 days after injury. EPO treatment can effectively prevent pathological alterations from severe spinal cord injury by reduced expression of TSP-1 and TGF-beta. Chin Med J 2009;122(14):1631-1635
引用
收藏
页码:1631 / 1635
页数:5
相关论文
共 50 条
  • [1] Protection of erythropoietin on experimental spinal cord injury by reducing the expression of thrombospondin-1 and transforming growth factor-β
    FANG Xiangqian FANG Mei FAN Shunwu GU Chuanlong Department of OrthopaedicsSir Run Run Shaw HospitalSchool of MedicineZhejiang UniversityHangzhouZhejiang China Sir Run Run Shaw Hospital School of Medicine Zhejiang UniversityHangzhouZhejiang ChinaDepartment of Cell Biology and AnatomySchool of MedicineZhejiang UniversityHangzhouZhejiang China
    中华医学杂志(英文版), 2009, (14) : 1631 - 1635
  • [2] The role of thrombospondin-1 and transforming growth factor-β after spinal cord injury in the rat
    Wang, Xianghua
    Chen, Weiping
    Liu, Wangmi
    Wu, Jiayan
    Shao, Yanqi
    Zhang, Xiaoming
    JOURNAL OF CLINICAL NEUROSCIENCE, 2009, 16 (06) : 818 - 821
  • [3] Correlation of thrombospondin-1 and transforming growth factor-β expression with malignancy of glioma
    Kawataki, T
    Naganuma, H
    Sasaki, A
    Yoshikawa, H
    Tasaka, K
    Nukui, H
    NEUROPATHOLOGY, 2000, 20 (03) : 161 - 169
  • [4] Investigation of thrombospondin-1 and transforming growth factor-β expression in the heart of aging mice
    Cai, Huabo
    Yuan, Zhanggen
    Fei, Qing
    Zhao, Jiayao
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 3 (03) : 433 - 436
  • [5] Effect of triptolide on expression of thrombospondin-1 and transforming growth factor-β1 in renal tubular cells
    Zeng, Rong
    Duan, Lei
    Sun, Lina
    Kong, Yuke
    Yang, Kehu
    RENAL FAILURE, 2015, 37 (06) : 1039 - 1043
  • [6] Thrombospondin-1 and Transforming Growth Factor-β1 Levels in Prolactinoma and Their Clinical Significance
    Jiang, M.
    Mou, C. Z.
    Han, T.
    Wang, M.
    Yang, W.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2012, 40 (04) : 1284 - 1294
  • [7] Localization of transforming growth factor-β1 and receptor mRNA after experimental spinal cord injury
    McTigue, DM
    Popovich, PG
    Morgan, TE
    Stokes, BT
    EXPERIMENTAL NEUROLOGY, 2000, 163 (01) : 220 - 230
  • [8] Expression of the type-1 repeats of thrombospondin-1 inhibits tumor growth through activation of transforming growth factor-β
    Yee, KO
    Streit, M
    Hawighorst, T
    Detmar, M
    Lawler, J
    AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (02): : 541 - 552
  • [9] Glucose stimulation of transforming growth factor-β bioactivity in mesangial cells is mediated by thrombospondin-1
    Poczatek, MH
    Hugo, C
    Darley-Usmar, V
    Murphy-Ullrich, JE
    AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (04): : 1353 - 1363
  • [10] Participation of thrombospondin-1 in the activation of latent transforming growth factor-β in malignant glioma cells
    Saya, H
    NEUROLOGIA MEDICO-CHIRURGICA, 2001, 41 (05): : 258 - 259